» Authors » Dongling Zhu

Dongling Zhu

Explore the profile of Dongling Zhu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 134
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Zhao Y, Yang Y, Zhang B, Cui H, Liu L, Wang R, et al.
MedComm (2020) . 2025 Feb; 6(3):e70117. PMID: 40008378
Intratumoral brachytherapy enables higher dose treatment and reduces damage to adjacent tissues. We first validated the feasibility and safety of endoscopic ultrasound (EUS)-guided Yttrium-90 (Y) microspheres implantation in a porcine...
2.
Zou S, Liu Z, Zhou J, Song S, Wang D, Zhu D, et al.
Eur J Nucl Med Mol Imaging . 2025 Feb; PMID: 39951137
Purpose: Recently, novel human epidermal growth factor receptor 2 antibody-drug conjugate therapies have shown remarkable efficacy in treating urothelial carcinoma, highlighting the growing need for comprehensive assessment of HER2 expression...
3.
Zhu D, Song S, Zou S, Kuang D, Wang D, Min X, et al.
Eur J Nucl Med Mol Imaging . 2025 Jan; PMID: 39831967
Purpose: To investigate the efficacy of [Ga]Ga-FAPI-04 PET/CT for assessing viable tumours (VTs) after local regional treatment (LRT) in hepatocellular carcinoma (HCC) patients. The related imaging features of HCC after...
4.
Zhou P, Zhang D, Fu J, Zhu D, Li S
Infect Drug Resist . 2024 Dec; 17:5729-5738. PMID: 39722737
Objective: To evaluate the value of respiratory specimens collected via different sampling methods combined with metagenomic next-generation sequencing (mNGS) in the etiological diagnosis of severe pneumonia. Methods: A total of...
5.
Chen L, Cheng S, Zhu D, Bao G, Wang Z, Deng X, et al.
Mol Pharm . 2024 Dec; 22(1):209-220. PMID: 39655726
Positron emission tomography (PET) is a promising modality for early diagnosis, accurate detection, and staging of hepatocellular carcinoma (HCC). Hereby, a dual-specific probe targeting Glypican-3 (GPC3) and prostate-specific membrane antigen...
6.
Zhu D, Song S, Wang D, Kuang D, Cheng S, Zhou J, et al.
Front Oncol . 2024 Feb; 14:1292313. PMID: 38361782
Perivascular epithelioid cell tumor (PEComa), an uncommon mesenchymal neoplasm, arises from specialized perivascular epithelioid cells exhibiting distinct features of smooth muscle and melanocytic differentiation with unpredictable behavior. PEComa tends to...
7.
Liu J, Tang M, Zhu D, Ruan G, Zou S, Cheng Z, et al.
EJNMMI Res . 2023 Oct; 13(1):94. PMID: 37902852
Background: Owing to the advances in diagnosis and therapy, survival or remission rates for lymphoma have improved prominently. Apart from the lymphoma- and chemotherapy-related somatic symptom burden, increasing attention has...
8.
Ma T, Qiu F, Gong Y, Cao H, Dai G, Sun D, et al.
Theranostics . 2023 Jul; 13(11):3826-3843. PMID: 37441584
Cardiac fibrosis is an adverse consequence of aberrant fibroblast activation and extracellular matrix (ECM) deposition following myocardial infarction (MI). Recently, long noncoding RNAs (lncRNAs) have been reported to participate in...
9.
Gao L, Qiu F, Cao H, Li H, Dai G, Ma T, et al.
Theranostics . 2023 Jan; 13(2):685-703. PMID: 36632217
Clinical application of mesenchymal stem cells (MSCs) and MSC-derived exosomes (MSC-Exos) to alleviate myocardial ischemia/reperfusion (I/R) injury is compromised by the low cell engraftment rate and uncontrolled exosomal content. As...
10.
Huang Z, Wen J, Wang Y, Han S, Li Z, Hu X, et al.
Front Med . 2022 Jul; 16(4):551-573. PMID: 35852753
Patients with hepatocellular carcinoma (HCC) and bone metastasis (BM) suffer from greatly reduced life quality and a dismal prognosis. However, BM in HCC has long been overlooked possibly due to...